Key facts
- It has raised $20.7M; the latest was Early Stage VC in Nov 2025.
- Notable investors include Zijin Hi-Tech Venture Capital, Nanjing Innovation Capital Group, Co-Win Ventures, Cenova Capital, Dingxin Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Fine Vision
- ·The full record, as it builds
Funding rounds
No funding rounds for Fine Vision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fine Vision
Developer of high-precision surgical laser systems intended for vision correction purposes. The company offers femtosecond laser generation, micron-level scanning optics, AI-enhanced surgical planning and real-time feedback control, serving ophthalmic clinics and surgical centers to perform minimally invasive, precise corneal refractive procedures with improved safety, consistency and clinical outcomes through automated visual guidance and smart interface design.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2022
- Website
- visualfine.com/
- Ownership
- Privately Held (backing)
Fine Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fine Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fine Vision in its N-PORT filings yet. We sweep new filings monthly.